CVM
Cel-Sci Corp.
Halal Rating :
Last Price
$0.40
Last updated:
Market Cap
-
7D Change
-3.69%
1 Year Change
-83.89%
Company Overview
Industries
Exchange
Next Earnings Date
CEL-SCI Corporation is a clinical-stage biotechnology company focused on developing immunotherapy products to treat cancer and infectious diseases. Their lead product candidate is Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for the treatment of head and neck cancer.
The company is currently in the pre-revenue stage, primarily focused on research and development activities.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Cel-Sci Corp.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.